| Effect of a novel antibiotic, heliquinomycin, on DNA helicase and cell growth. | |
| | |
MedLine Citation:
|
PMID: 9666176 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Heliquinomycin, a novel microbial product, was found to inhibit a human DNA helicase enzyme isolated from HeLa S3 cells at concentrations of 5 to 10 micrograms/ml. In contrast, adriamycin, etoposide and cisplatin did not inhibit this enzyme at the concentrations tested. Furthermore, the replication and repair of SV40 chromosome were not affected at heliquinomycin concentration of 50 micrograms/ml. The topoisomerase II and I enzymes were inhibited at 30 micrograms/ml and 100 micrograms/ml of heliquinomycin, respectively. Heliquinomycin inhibited the growth of HeLa S3, KB, LS180, K562 and HL60 human tumor cell lines at IC50 values of 0.96 to 2.8 micrograms/ml. In addition, the growth of adriamycin and cisplatin resistant P388 cell lines were inhibited at similar concentrations. Heliquinomycin inhibited both DNA and RNA synthesis in cell culture but did not inhibit protein synthesis. HeLa S3 cells were arrested at the G2/M phase by heliquinomycin. These studies suggest that heliquinomycin is a selective inhibitor of a cellular DNA helicase and in turn, inhibits growth of tumor cell lines. |
| | |
Authors:
|
M Chino; K Nishikawa; A Yamada; M Ohsono; T Sawa; F Hanaoka; M Ishizuka; T Takeuchi |
Related Documents
:
|
22079866 - Photoligation of self-assembled dna constructs containing anthracene-functionalized 2'-... 1540136 - Damage-recognition proteins as a potential indicator of dna-damage-mediated sensitivity... 1805936 - A novel technique to assay adducts of dna induced by anticancer agent cis-diamminedichl... 18646876 - Noncovalent functionalization of dna-wrapped single-walled carbon nanotubes with platin... 6094546 - Cleavage of phosphorothioate-substituted dna by restriction endonucleases. 18715646 - Structural basis and functional effects of the interaction between complement inhibitor... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The Journal of antibiotics Volume: 51 ISSN: 0021-8820 ISO Abbreviation: J. Antibiot. Publication Date: 1998 May |
Date Detail:
|
Created Date: 1998-07-31 Completed Date: 1998-07-31 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0151115 Medline TA: J Antibiot (Tokyo) Country: JAPAN |
Other Details:
|
Languages: eng Pagination: 480-6 Citation Subset: IM |
Affiliation:
|
Institute of Microbial Chemistry, Tokyo Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antibiotics, Antineoplastic
/
chemistry,
pharmacology* Benzoquinones / chemistry, pharmacology Cell Cycle / drug effects Cell-Free System DNA / drug effects DNA Helicases / antagonists & inhibitors* DNA Repair DNA Replication / drug effects DNA Topoisomerases, Type I / metabolism Drug Screening Assays, Antitumor Enzyme Inhibitors / chemistry, pharmacology* Humans Hydrolysis Molecular Structure Spiro Compounds / chemistry, pharmacology Tumor Cells, Cultured |
| Chemical | |
Reg. No./Substance:
|
0/Antibiotics, Antineoplastic; 0/Benzoquinones; 0/Enzyme Inhibitors; 0/Spiro Compounds; 0/heliquinomycin; 9007-49-2/DNA; EC 3.6.1.-/DNA Helicases; EC 5.99.1.2/DNA Topoisomerases, Type I |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Screening systems for detecting inhibitors of cell wall transglycosylation in Enterococcus. Cell wal...
Next Document: Antifungal activities of rapamycin and its derivatives, prolylrapamycin, 32-desmethylrapamycin, and ...